FeNO and asthma treatment in children: A systematic review and meta-analysis

Medicine (United States)

Volumn 94, Issue 4, 2015, Pages

  Lu, Min ^a   Wu, Beirong ^a   Che, Datian ^a   Qiao, Rong ^a   Gu, Haoxiang ^a  

^a SHANGHAI CHILDREN S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NITRIC OXIDE; STEROID; ANTIASTHMATIC AGENT; BIOLOGICAL MARKER; GLUCOCORTICOID;

ARTICLE; ASTHMA; CHILD; DRUG USE; EXHALATION; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SPIROMETRY; STEROID THERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION; DECISION MAKING; DRUG MONITORING; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PROCEDURES;

ADMINISTRATION, INHALATION; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL MARKERS; CHILD; DECISION MAKING; DRUG MONITORING; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; NITRIC OXIDE;

EID: 84938098712     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000347     Document Type: Article

References (26)

1. Corrarino J. New guidelines for diagnosis and management of asthma. MCN Am J Matern Child Nurs. 2008; 33:136.
2. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002; 360:1715-1721.
3. Smith AD, Cowan JO, Brassett K.P., et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005; 352:2163-2173.
4. Pijnenburg MW, Bakker EM, Hop W.C., et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med. 2005; 172:831-836.
5. Fritsch M, Uxa S, Horak F Jr et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol. 2006; 41:855-862.
6. Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med. 2007; 176:231-237.
7. Payne DN, Adcock IM, Wilson N.M., et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001; 164:1376-1381.
8. Jatakanon A, Lim S, Kharitonov S.A., et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998; 53:91-95.
9. Jones SL, Kittelson J, Cowan J.O., et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001; 164:738-743.
10. Barnes PJ, Dweik RA, Gelb A.F., et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010; 138:682-692.
11. Kharitonov SA, Donnelly LE, Montuschi P, et al. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax. 2002; 57:889-896.
12. Franklin PJ, Stick SM. The value of FeNO measurement in asthma management: the motion against FeNO to help manage childhood asthma-reality bites. Paediatr Respir Rev. 2008; 9:122-126.
13. Bush A, Eber E. The value of FeNO measurement in asthma management: the motion for Yes, it's NO-or, the wrong end of the Stick! Paediatr Respir Rev. 2008; 9:127-131.
14. Jouaville LF, Annesi-Maesano I, Nguyen L.T., et al. Interrelationships among asthma, atopy, rhinitis and exhaled nitric oxide in a population-based sample of children. Clin Exp Allergy. 2003; 33:1506-1511.
15. Franklin PJ, Turner SW, Le Souef PN, et al. Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax. 2003; 58:1048-1052.
16. Buchvald F, Baraldi E, Carraro S., et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol. 2005; 115:1130-1136.
17. Jackson DJ, Virnig CM, Gangnon R.E., et al. Fractional exhaled nitric oxide measurements are most closely associated with allergic sensitization in school-age children. J Allergy Clin Immunol. 2009; 124:949-953.
18. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005; 5:13.
19. de Jongste JC, Carraro S, Hop W.C., et al. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med. 2009; 179:93-97.
20. Peirsman EJ, Carvelli TJ, Hage P.Y., et al. Exhaled nitric oxide in childhood allergic asthma management: a randomised controlled trial. Pediatr Pulmonol. 2014; 49:624-631.
21. Pike K, Selby A, Price S., et al. Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial. Clin Respir J. 2012.
22. Szefler SJ, Mitchell H, Sorkness C.A., et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008; 372:1065-1072.
23. Sutton AJ, Duval SJ, Tweedie R.L., et al. Empirical assessment of effect of publication bias on meta-analyses. BMJ. 2000; 320:1574-1577.
24. Petsky HL, Cates CJ, Li A, et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2009:CD006340.
25. Jartti T, Wendelin-Saarenhovi M, Heinonen I., et al. Childhood asthma management guided by repeated FeNO measurements: a meta-analysis. Paediatr Respir Rev. 2012; 13:178-183.
26. Petsky HL, Cates CJ, Lasserson T.J., et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax. 2012; 67:199-208.